Old API Wind-down Ltd. Stock

Stocks

ARLZQ

CA03852X1006

Pharmaceuticals

OTC Markets Traded
Delayed OTC Markets 5-day change 1st Jan Change
- USD -.--% Intraday chart for Old API Wind-down Ltd. -.--% -

Valuation: Old API Wind-down Ltd.

Market Cap 87.35K 76.75K 71.17K 65.44K 124K 8.35M 126K 848K 332K 4.1M 328K 321K 14.19M P/E 2016
-2.53x
P/E 2017 -0.75x
Enterprise Value 246M 216M 200M 184M 348M 23.5B 355M 2.39B 934M 11.54B 923M 903M 39.91B EV / Sales 2016
9.18x
EV / Sales 2017 3.22x
Free-Float
100%
Yield 2016 *
-
Yield 2017 -
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 0
-0.56%-2.64%+49.04%+168.24% 1,060B
+0.31%-2.00%+64.29%+63.06% 619B
-0.03%-5.01%+28.86%+83.73% 438B
-1.75%-2.91%+28.78%+24.35% 333B
+0.24%-2.61%+29.46%+46.50% 282B
-1.75%-12.77%+20.67%+23.05% 267B
+0.67%-0.76%-26.10%-37.25% 218B
-0.81%-3.66%+22.07%+59.72% 196B
+1.21%+0.10%+19.85%+72.03% 161B
Average -0.12%-3.00%+26.32%+55.94% 357.39B
Weighted average by Cap. +0.03%-3.10%+36.27%+82.99%

Financials

2016 2017
Net sales 54.27M 47.68M 44.21M 40.65M 76.81M 5.19B 78.43M 527M 206M 2.55B 204M 199M 8.81B 106M 93.08M 86.32M 79.37M 150M 10.13B 153M 1.03B 402M 4.98B 398M 389M 17.21B
Net income -103M -90.47M -83.9M -77.14M -146M -9.85B -149M -1B -391M -4.84B -387M -378M -16.73B -125M -110M -102M -93.79M -177M -11.97B -181M -1.22B -476M -5.88B -470M -460M -20.34B
Net Debt 209M 184M 171M 157M 297M 20.03B 303M 2.03B 796M 9.84B 787M 769M 34.03B 246M 216M 200M 184M 348M 23.49B 355M 2.39B 933M 11.54B 922M 902M 39.9B
Logo Old API Wind-down Ltd.
Old API Wind-Down Ltd, formerly Aralez Pharmaceuticals Inc., is a Canada-based specialty pharmaceutical company. The Company focuses on acquiring, developing and commercializing products in cardiovascular, pain and other areas. The Company's products include Fibricor, Cambia, Fiorinal, Fiorinal C, Soriatane, Bezalip SR, NeoVisc, Uracyst, Durela, Proferrin, Resultz and Collatamp G. Its development products include YOSPRALA and Bilastine. Fibricor (fenofibric acid) is indicated as a complementary therapy along with diet for the treatment of hypertriglyceridemia, and as a complementary therapy along with diet to reduce elevated low-density lipoprotein cholesterol (LDL-C), total cholesterol (Total-C), triglycerides (TG) and apolipoprotein B (Apo B). Fibricor is also used to increase high-density lipoprotein (HDL) cholesterol (HDL-C) in patients with hypercholesterolemia or mixed dyslipidemia. Cambia (diclofenac potassium for oral solution) is a non-steroidal anti-inflammatory drug (NSAID).
Employees
-
  1. Stock Market
  2. Stocks
  3. ARLZQ Stock